Headlands Technologies LLC Buys 9,690 Shares of Veradigm Inc. (NASDAQ:MDRX)

Headlands Technologies LLC grew its position in shares of Veradigm Inc. (NASDAQ:MDRX) by 14,907.7% in the 4th quarter, Holdings Channel reports. The firm owned 9,755 shares of the software maker’s stock after acquiring an additional 9,690 shares during the quarter. Headlands Technologies LLC’s holdings in Veradigm were worth $102,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Pacer Advisors Inc. increased its position in shares of Veradigm by 108.1% during the fourth quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock worth $26,399,000 after buying an additional 1,307,024 shares during the period. Wellington Management Group LLP grew its holdings in Veradigm by 92.5% during the 3rd quarter. Wellington Management Group LLP now owns 2,665,814 shares of the software maker’s stock worth $35,029,000 after acquiring an additional 1,281,319 shares during the period. William Blair Investment Management LLC raised its position in shares of Veradigm by 16.6% in the 3rd quarter. William Blair Investment Management LLC now owns 4,375,005 shares of the software maker’s stock worth $57,488,000 after acquiring an additional 623,438 shares in the last quarter. Creative Planning lifted its stake in shares of Veradigm by 2,848.4% in the 3rd quarter. Creative Planning now owns 474,376 shares of the software maker’s stock valued at $6,233,000 after purchasing an additional 458,287 shares during the period. Finally, abrdn plc bought a new stake in Veradigm in the fourth quarter worth approximately $4,496,000.

Veradigm Stock Performance

Shares of MDRX stock opened at $7.98 on Tuesday. Veradigm Inc. has a 12 month low of $5.01 and a 12 month high of $14.09. The firm has a fifty day simple moving average of $7.74 and a two-hundred day simple moving average of $9.82.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on MDRX shares. Barclays started coverage on Veradigm in a report on Wednesday, January 3rd. They set an “equal weight” rating and a $11.00 price target on the stock. StockNews.com assumed coverage on shares of Veradigm in a research note on Tuesday, April 23rd. They set a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $10.00 price target (down from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Finally, Royal Bank of Canada cut their price objective on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a research report on Friday, January 19th. Five investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $11.25.

Veradigm Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.